Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
Hung-Hsien Chiang,1 Deng-Chyang Wu,2 Pin-I Hsu,3 Chao-Hung Kuo,2 Wei-Chen Tai,1 Shih-Cheng Yang,1 Keng-Liang Wu,1 Chih-Chien Yao,1 Cheng-En Tsai,1 Chih-Ming Liang,1 Yao-Kuang Wang,2 Jiunn-Wei Wang,2 Chih-Fang Huang,4 Seng-Kee Chuah,1 on behalf of the Taiwan Acid-Related Disease St...
Na minha lista:
Principais autores: | Chiang HH (Autor), Wu DC (Autor), Hsu PI (Autor), Kuo CH (Autor), Tai WC (Autor), Yang SC (Autor), Wu KL (Autor), Yao CC (Autor), Tsai CE (Autor), Liang CM (Autor), Wang YK (Autor), Wang JW (Autor), Huang CF (Autor), Chuah SK (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
Dove Medical Press,
2019-04-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Managing gastroesophageal reflux disease – comparative efficacy and outcomes of dexlansoprazole MR
por: Frye JW, et al.
Publicado em: (2015) -
Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects
por: Kim HC, et al.
Publicado em: (2023) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
por: Cardile S, et al.
Publicado em: (2012) -
Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
por: Mingxing HOU, et al.
Publicado em: (2020) -
Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: Focus on delayed-release esomeprazole
por: Elizabet V Guimarães, et al.
Publicado em: (2010)